Ubiquitin, the peptide 'tag' that targets eukaryotic proteins for degradation by the proteasome, has also been implicated in transcriptional activation. The mechanism of gene activation might include recruitment of a transcriptional elongation factor by ubiquitinated activators. Three aspects of these experiments suggest that transcriptional elongation was boosted. First, the activation was observed using either a DNA-based tether (LexA binding to a promoter sequence) or an RNA-based tether (Rev binding to an initial portion of the reporter gene transcript). Second, the stimulation was blocked by a dominant-negative form of the Cdk9
the activity of an activator at times when its target genes should not be expressed, or to quench its activity so that the transcriptional response to a stimulus can be quickly dampened. Interestingly, the activation domains of many regulatory proteins overlap with the signals responsible for the degradation [2,10,11], leading to the suggestion that destruction of the activator might be a requisite step in the mechanism of transcriptional activation [ [19, 20] . In these studies, the function of a given activator protein was diminished in cells lacking the appropriate ubiquitin ligase -which attaches ubiquitin to specific target proteins -but the transcriptional function was restored by genetically fusing the ubiquitin polypeptide to the activator protein.
Kurosu and Peterlin [3] report evidence suggesting an explicit mechanism by which ubiquitination of activators might facilitate transcriptional elongation. They constructed chimeric genes joining the activation domain of VP16 -wild-type or mutant versionswith either the LexA DNA-binding domain (LexA-VP16) or the RNA-binding domain of the HIV Rev protein (Rev-VP16). When the fusion proteins bearing the wild-type VP16 activation domain were expressed in mammalian cells, they were ubiquitinated and they stimulated expression of cognate reporter genes.
Three aspects of these experiments suggest that transcriptional elongation was boosted. First, the activation was observed using either a DNA-based tether (LexA binding to a promoter sequence) or an RNA-based tether (Rev binding to an initial portion of the reporter gene transcript). Second, the stimulation was blocked by a dominant-negative form of the Cdk9 protein, indicating that the transcriptional activation depended on P-TEFb. And third, use of the mutant VP16 domain resulted in less abundant expression of distal regions of the reporter gene relative to more proximal segments, suggesting pausing or premature termination of transcription.
The real news derives from additional experiments that point quite directly to a role for ubiquitin in this transcriptional elongation activity. When ubiquitin was artificially fused to LexA-VP16 -generating ubiquitin-LexA-VP16 -expression of the reporter gene was augmented and the deleterious effect of the VP16 F442A mutation was suppressed. LexA-VP16 was shown to bind to the CycT1 subunit of P-TEFb in vitro, and ubiquitin-LexA-VP16 bound even more avidly to CycT1. In fact, VP16 and ubiquitin bound to different regions of CycT1, so when both are present the interaction is stronger. The model that emerges is that the presence of ubiquitin attached to an activator protein results in enhanced recruitment of P-TEFb and thus enhanced transcriptional elongation (Figure 1) .
One caveat for these experiments arises from the use of highly artificial fusion proteins and reporter genes, and so it will be important to test this hypothesis in more native biological contexts. Nonetheless, the strength of the new report by Kurosu 
